This Clinical Trial is being conducted to study the LDL (bad) cholesterol lowering abilities of flax. The purpose of this study is to find the lowest dose of flax that can lower LDL-cholesterol.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Enrollment
76
Asper Clinical Research Institute
Winnipeg, Manitoba, Canada
Glycemic Index Laboratories Inc.
Toronto, Ontario, Canada
lipid profile
plasma total cholesterol, HDL, LDL and triglycerides
Time frame: 4 weeks
flax metabolites
plasma enterolignans and phospholipid fatty acid composition
Time frame: 4 weeks
blood pressure
Time frame: 4 weeks
high sensitivity c-reactive protein (hsCRP)
Time frame: 4 weeks
glucose
Time frame: 4 weeks
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.